Page last updated: 2024-10-26

valproic acid and Diffuse Parenchymal Lung Disease

valproic acid has been researched along with Diffuse Parenchymal Lung Disease in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research Excerpts

ExcerptRelevanceReference
"We diagnosed interstitial pneumonitis (IP) based on her chest CT and high serum concentrations of KL-6 and surfactant protein D."1.34[Valproate sodium and zonisamide associated interstitial pneumonitis in an infant]. ( Doi, T; Kato, T; Nikaido, K; Takayama, R, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saravanan, N1
Otaiku, OM1
Namushi, RN1
Nikaido, K1
Kato, T1
Takayama, R1
Doi, T1

Other Studies

2 other studies available for valproic acid and Diffuse Parenchymal Lung Disease

ArticleYear
Interstitial pneumonitis during lamotrigine therapy.
    British journal of clinical pharmacology, 2005, Volume: 60, Issue:6

    Topics: Anticonvulsants; Drug Therapy, Combination; Female; Humans; Lamotrigine; Lung Diseases, Interstitial

2005
[Valproate sodium and zonisamide associated interstitial pneumonitis in an infant].
    No to hattatsu = Brain and development, 2007, Volume: 39, Issue:1

    Topics: Anticonvulsants; Epilepsy; Female; Humans; Infant; Isoxazoles; Lung Diseases, Interstitial; Respirat

2007